New and developing therapies for AL amyloidosis.

about

A Peptide-Fc Opsonin with Pan-Amyloid Reactivity The proteasome and proteasome inhibitors in multiple myeloma.Isolated Laryngeal Amyloidosis Mimicking Laryngeal Cancer

P2860

Q41471564-DF0AE556-A058-42AD-BD01-281E1390A7AF Q47339695-3564FC4C-0D24-471E-A393-26493D6A0A71 Q58798131-12D5F340-160E-4720-B2B1-F5F4975C9E0C

P2860

New and developing therapies for AL amyloidosis.

Item

http://www.wikidata.org/entity/Q38779623

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

New and developing therapies for AL amyloidosis.

@en

type

Item

label

New and developing therapies for AL amyloidosis.

@en

prefLabel

New and developing therapies for AL amyloidosis.

@en

P1476

New and developing therapies for AL amyloidosis.

@en

P2093

Marianna Fontana

http://www.w3.org/2001/XMLSchema#string

Omid Sadeghi-Alavijeh

http://www.w3.org/2001/XMLSchema#string

Philip N Hawkins

http://www.w3.org/2001/XMLSchema#string

P2860

Update on treatment of light chain amyloidosis

Implantable cardioverter defibrillators in patients with cardiac amyloidosis.

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis

P304

139-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1274971

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giulia Zumbo

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28002971

http://www.w3.org/2001/XMLSchema#string

New and developing therapies for AL amyloidosis.

about

P2860

P2860

New and developing therapies for AL amyloidosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698